CMMI issues summary of COVID-19-related adjustments for alternative payment models
The Center for Medicare and Medicaid Innovation today announced several COVID-19-related modifications to current and future CMMI alternative payment models. The adjustments are captured in a summary table and are related to the models’ financial methodologies, quality reporting requirements and timelines.
The AHA said it is pleased that CMMI is providing these flexibilities, many of which we have actively advocated for, and is eager to understand additional detail about these changes, which CMMI indicated will be released on a rolling basis.
Related News Articles
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug…
Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for…